Introduction:Basic information about CAS 27591-69-1|Tilorone dihydrochloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Tilorone dihydrochloride |
|---|
| CAS Number | 27591-69-1 | Molecular Weight | 483.471 |
|---|
| Density | 1.102g/cm3 | Boiling Point | 552.3ºC at 760 mmHg |
|---|
| Molecular Formula | C25H36Cl2N2O3 | Melting Point | 230-233 °C(lit.) |
|---|
| MSDS | ChineseUSA | Flash Point | 287.8ºC |
|---|
| Symbol | GHS07, GHS08 | Signal Word | Warning |
|---|
Names
| Name | Tilorone dihydrochloride |
|---|
| Synonym | More Synonyms |
|---|
Tilorone dihydrochloride BiologicalActivity
| Description | Tilorone dihydrochloride is the first recognized synthetic, small molecular weight compound that is an orally active interferon inducer, used as an antiviral drug. |
|---|
| Related Catalog | Signaling Pathways >>Metabolic Enzyme/Protease >>HIF/HIF Prolyl-HydroxylaseResearch Areas >>Infection |
|---|
Chemical & Physical Properties
| Density | 1.102g/cm3 |
|---|
| Boiling Point | 552.3ºC at 760 mmHg |
|---|
| Melting Point | 230-233 °C(lit.) |
|---|
| Molecular Formula | C25H36Cl2N2O3 |
|---|
| Molecular Weight | 483.471 |
|---|
| Flash Point | 287.8ºC |
|---|
| Exact Mass | 482.210297 |
|---|
| PSA | 42.01000 |
|---|
| LogP | 5.94320 |
|---|
| Vapour Pressure | 3.05E-12mmHg at 25°C |
|---|
| InChIKey | BSVYJQAWONIOOU-UHFFFAOYSA-N |
|---|
| SMILES | CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2.Cl.Cl |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- LL9000000
- CHEMICAL NAME :
- Fluoren-9-one, 2,7-bis(2-(diethylamino)ethoxy)-, dihydrochloride
- CAS REGISTRY NUMBER :
- 27591-69-1
- LAST UPDATED :
- 199606
- DATA ITEMS CITED :
- 17
- MOLECULAR FORMULA :
- C25-H34-N2-O3.2Cl-H
- MOLECULAR WEIGHT :
- 483.53
- WISWESSER LINE NOTATION :
- L B656 HVJ EO2N2&2 LO2N2&2 &GH 2
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human
- DOSE/DURATION :
- 4 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Behavioral - anorexia (human) Gastrointestinal - hypermotility, diarrhea
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 852 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 244 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 800 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 145 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 53500 ug/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Behavioral - muscle contraction or spasticity Lungs, Thorax, or Respiration - dyspnea
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 150 mg/kg/5D-I
- TOXIC EFFECTS :
- Related to Chronic Data - death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 250 mg/kg
- SEX/DURATION :
- female 10 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Effects on Embryo or Fetus - fetal death
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- DOSE :
- 400 mg/kg
- SEX/DURATION :
- female 10 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Maternal Effects - other effects Reproductive - Effects on Embryo or Fetus - fetal death
MUTATION DATA - TYPE OF TEST :
- DNA adduct
- TEST SYSTEM :
- Mammal - species unspecified Lymphocyte
- DOSE/DURATION :
- 100 umol/L
- REFERENCE :
- FEBLAL FEBS Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1968- Volume(issue)/page/year: 28,5,1972 *** REVIEWS *** TOXICOLOGY REVIEW CRTXB2 CRC Critical Reviews in Toxicology. (CRC Press, Inc., 2000 Corporate Blvd., NW, Boca Raton, FL 33431) V.1- 1971- Volume(issue)/page/year: 2,159,1973
|
Safety Information
| Symbol | GHS07, GHS08 |
|---|
| Signal Word | Warning |
|---|
| Hazard Statements | H302 + H312 + H332-H315-H319-H335-H351 |
|---|
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
|---|
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|
| Hazard Codes | Xi: Irritant; |
|---|
| Risk Phrases | R20/21/22;R36/37/38;R40 |
|---|
| Safety Phrases | S7-S22-S26-S37/39 |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| WGK Germany | 3 |
|---|
| RTECS | LL9000000 |
|---|
| HS Code | 2922509090 |
|---|
Customs
| HS Code | 2922509090 |
|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|---|
Articles29
More Articles
| Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose. Pharmazie 68(10) , 796-9, (2013) The objective of this research was to develop and evaluate sustained-release matrix tablets of BKP-01-041 (tilorone derivative) based on Hypromellose (hydroxypropyl methylcellulose, HPMC) as the matri... | |
| SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophore. Bioorg. Med. Chem. Lett. 22 , 1633-8, (2012) The well-known interferon-inducer tilorone was found to possess potent affinity for the agonist site of the α7 neuronal nicotinic receptor (K(i)=56 nM). SAR investigations determined that both basic s... | |
| Discovery of inhibitors of Bacillus anthracis primase DnaG. Biochemistry 52(39) , 6905-10, (2013) Primase DnaG is an essential bacterial enzyme that synthesizes short ribonucleotide primers required for chromosomal DNA replication. Inhibitors of DnaG can serve as leads for development of new antib... | |
Synonyms
| 9H-Fluoren-9-one, 2,7-bis[2-(diethylamino)ethoxy]-, hydrochloride (1:2) |
| 2,7-Bis-deae-fluorenone |
| 2,7-Bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride |
| 2,7-Bis(2-diethylaminoethoxy)fluoren-9-one dihydrochloride |
| bis-deae-fluorenonehydrochloride |
| TILORONE HYDROCHLORIDE |
| TILORONE 2HCL |
| 2,7-Bis[2-(diethylamino)ethoxy]-9-fluorenone dihydrochloride |
| MFCD00134071 |
| 9H-Fluoren-9-one, 2,7-bis[2- (diethylamino)ethoxy]-, dihydrochloride |
| Tilorone DiHCl |
| Deae-f |
| 2,7-Bis[2-(diethylamino)ethoxy]-9H-fluoren-9-one dihydrochloride |
| UNII-BJ507J4LKY |
| Tilorone (dihydrochloride) |